DrugPatentWatch Database Preview
Secura Company Profile
Email this page to a colleague
See Plans and PricingWhat is the competitive landscape for SECURA, and when can generic versions of SECURA drugs launch?
SECURA has one approved drug.
There are five US patents protecting SECURA drugs.
There are one hundred and five patent family members on SECURA drugs in forty-seven countries and fourteen supplementary protection certificates in twelve countries.
Summary for Secura
| International Patents: | 105 |
| US Patents: | 5 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Secura
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Secura | FARYDAK | panobinostat lactate | CAPSULE;ORAL | 205353-001 | Feb 23, 2015 | RX | Yes | No | 6,552,065 | Start Trial | Y | Y | Start Trial | ||
| Secura | FARYDAK | panobinostat lactate | CAPSULE;ORAL | 205353-003 | Feb 23, 2015 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| Secura | FARYDAK | panobinostat lactate | CAPSULE;ORAL | 205353-003 | Feb 23, 2015 | RX | Yes | Yes | 8,883,842 | Start Trial | Start Trial | ||||
| Secura | FARYDAK | panobinostat lactate | CAPSULE;ORAL | 205353-003 | Feb 23, 2015 | RX | Yes | Yes | 7,989,494 | Start Trial | Y | Y | Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Secura Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Korea | 100585484 | Start Trial |
| Mexico | 2008001610 | Start Trial |
| Canada | 2650263 | Start Trial |
| Japan | 2009540006 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Secura Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1912640 | C20160001 00181 | Estonia | Start Trial | PRODUCT NAME: PANOBINOSTAAT;REG NO/DATE: EU/1/15/1023 01.09.2015 |
| 1318980 | 92890 | Luxembourg | Start Trial | PRODUCT NAME: PANOBINSTAT OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE , OU UN DERIVE DE CELUI-CI (FARYDAK); FIRST REGISTRATION: 20150901 |
| 1318980 | 122015000098 | Germany | Start Trial | PRODUCT NAME: PANOBINOSTAT ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ ODER DERIVAT HIERVON; REGISTRATION NO/DATE: EU/1/15/1023 20150828 |
| 1318980 | CA 2015 00068 | Denmark | Start Trial | PRODUCT NAME: PANOBINOSTAT ELLER ET FARMACEUTISK SALT ELLER DERIVAT DERAF; REG. NO/DATE: EU/1/15/1023 20150901 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
